Banque Cantonale Vaudoise’s Ascendis Pharma A/S ASND Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-495	Closed	-$79K	–	1337
2021 Q3	$79K	Buy	+495	New	+$67.7K	﹤0.01%	983
2020 Q1	–	Sell	-628	Closed	-$87K	–	919
2019 Q4	$87K	Buy	+628	New	+$69.8K	0.01%	824

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Banque Cantonale Vaudoise's ASND Position: Q4 2021 in Review

Banque Cantonale Vaudoise sold out of Ascendis Pharma A/S (ASND) in Q4 2021, closing a stake of 495 shares — an estimated $79K sold.

Banque Cantonale Vaudoise first reported a position in ASND in Q4 2019 and held it in 2 quarters. The position peaked at $87K in Q4 2019. 172 funds tracked by Wall St. Rank hold ASND as of Q4 2021.

Banque Cantonale Vaudoise reported no remaining Ascendis Pharma A/S position as of Q4 2021 after selling out during the quarter.
Banque Cantonale Vaudoise sold 495 Ascendis Pharma A/S shares in Q4 2021, an estimated $79K.
Banque Cantonale Vaudoise first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 2 quarters.
Banque Cantonale Vaudoise's Ascendis Pharma A/S position peaked at $87K in Q4 2019.
172 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2021, filed 14 Feb 2022.